Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Research news

Psilocybin therapy and personality parameters

July 11, 2018

Leo Sher, M.D.

A research report, “Effects of psilocybin therapy on personality structure” has been published in Acta Psychiatrica Scandinavica online ahead of print (1). The authors state that the goal of their study was to investigate whether psilocybin with psychological support modulates personality parameters in patients with treatment-resistant depression,  to examine whether these alterations correlate with the quality of the psychedelic experience and to examine whether such modulations could help us understand the long-term effects of psilocybin therapy.

Twenty individuals with unipolar major depression of at least moderate severity (≥17 on the 21-item Hamilton Depression Rating Scale) and no improvement despite two courses of pharmacologically dissimilar antidepressant drugs for an adequate time were enrolled in this open-labeled study.  Patients attended a preparation visit, followed by two dosing sessions, separated by one week. During the first and second sessions patients received 10 mg and 25 mg of psilocybin, respectively.

Personality was evaluated using the Revised NEO Personality Inventory (NEO-PI-R), which covers 5 domains, Neuroticism (anxious, insecure, emotional), Extraversion (sociable, optimistic, talkative), Openness to Experience (or short: Openness) (curious, imaginative, creative), Conscientiousness (hard-working, ambitious, persistent), and Agreeableness (good-natured, cooperative, helpful). Baseline vs. 3-month follow-up NEO-PI-R scores were compared. The subjective experience under psilocybin was evaluated using the Altered State of Consciousness Questionnaire (ASC). The Quick Inventory of Depressive Symptoms, (QIDS-SR16) was used to assess depressive symptoms at baseline and at selected time points.

The authors found that personality trait Neuroticism reduced, while traits Extraversion, Conscientiousness (trend-level), and Openness all increased from baseline to the 3-month follow-up after psilocybin therapy for treatment-resistant depression. The degree of insightfulness during the psychedelic experience predicted changes in Neuroticism and Extraversion. The authors suggest that the increases in Extraversion and Openness might constitute an effect more specific to therapy with a psychedelic.

Reference

1. Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL. Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand. 2018 Jun 19. doi: 10.1111/acps.12904. [Epub ahead of print]

Related Posts

Research news /

Blood alcohol concentration and suicide mortality in Finland

Research news /

Suicide risk in older adults: clinical responsibilities and medico-legal considerations

Research news /

Conceptualizing a combat veteran’s suicide death through the stress-diathesis model

‹ FDA Nutrition Facts Labels › Interview with Professor Steven Bernard Lippmann

Editorials

  • The role of the h-index in academic medicine
  • A timeless commitment: Reflections on the Hippocratic Oath
  • Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  
  • Suicide medical malpractice: A conceptual perspective

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Blood alcohol concentration and suicide mortality in Finland
  • Suicide risk in older adults: clinical responsibilities and medico-legal considerations
  • Conceptualizing a combat veteran’s suicide death through the stress-diathesis model
  • No evidence of a causal link between glucagon-like peptide-1 receptor agonists and suicidal behavior

Latest News

  • FDA launches real-time clinical trial initiative
  • The 2025 ScholarGPS rankings of leading scholars in suicidology
  • Mental health support for healthcare professionals
  • The 2024 ScholarGPS ranking of scholars in the field of suicidology

Interviews with eminent psychiatrists

  • 2026 Interview with Professor Zoltan Rihmer
  • 2026 Interview with Doctor María Dolores Braquehais Conesa
  • 2026 Interview with Professor Shih-Ku Lin
  • Interview with Professor Jess G. Fiedorowicz

Ten Years Ago

  • Suicide malpractice
  • Testosterone levels and future suicide attempts in women with bipolar disorder
  • Bipolar disorder, testosterone administration, and homicide
  • The cosyntropin stimulation test in military veterans with or without posttraumatic stress disorder

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2025 AVCalc LLC. All rights reserved worldwide.